EMMA (Emmaus Life Sciences) Change In Inventory: $-0.57 Mil (TTM As of Mar. 2026)


What is Emmaus Life Sciences Change In Inventory?

Emmaus Life Sciences EMMA Change In Inventory is $-0.57 Mil as of Mar. 2026. The stock has 6 warning signs investors should review.

Emmaus Life Sciences's change in inventory for the quarter that ended in Mar. 2026 was $-0.35 Mil. It means Emmaus Life Sciences's inventory increased by $0.35 Mil from Dec. 2025 to Mar. 2026 .

Emmaus Life Sciences's change in inventory for the fiscal year that ended in Dec. 2025 was $-0.02 Mil. It means Emmaus Life Sciences's inventory increased by $0.02 Mil from Dec. 2024 to Dec. 2025 .

Emmaus Life Sciences's Total Inventories for the quarter that ended in Mar. 2026 was $1.91 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Emmaus Life Sciences's Days Inventory for the quarter that ended in Mar. 2026 was 940.74.

Inventory Turnover measures how fast the company turns over its inventory within a year. Emmaus Life Sciences's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.10.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Emmaus Life Sciences's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.87.

Emmaus Life Sciences  (OTCPK:EMMA) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Emmaus Life Sciences's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=1.732/0.168*365 / 4
=940.74

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Emmaus Life Sciences's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=0.168 / 1.732
=0.10

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Emmaus Life Sciences's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=1.732 / 1.982
=0.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emmaus Life Sciences Change In Inventory Related Terms

Emmaus Life Sciences Change In Inventory Historical Data

* Premium members only.

The historical data trend for Emmaus Life Sciences's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Emmaus Life Sciences Change In Inventory Chart

Emmaus Life Sciences Annual Data
Trend Sep16 Sep17 Sep18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.46 0.43 0.65 0.01 -0.02

Emmaus Life Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.12 0.11 -0.45 -0.35

Emmaus Life Sciences Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of $-0.57 Mil mean?
Emmaus Life Sciences (EMMA) has a Change In Inventory of $-0.57 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Emmaus Life Sciences and its competitors.
Is Emmaus Life Sciences' Change In Inventory too high?
Emmaus Life Sciences' current Change In Inventory is $-0.57 Mil.
How does Emmaus Life Sciences' Change In Inventory compare to PTIX and BZYR?
Emmaus Life Sciences' Change In Inventory of $-0.57 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Emmaus Life Sciences and its competitors. Emmaus Life Sciences's current Change In Inventory is $-0.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Emmaus Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, Emmaus Life Sciences (EMMA) is currently considered Modestly Overvalued. The stock's GF Value™ is $0.01, compared to a current price of $0.01 — trading 11% above its estimated fair value. The current Change In Inventory is $-0.57 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Emmaus Life Sciences (EMMA), the current Change In Inventory is $-0.57 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Emmaus Life Sciences Business Description

Address 21250 Hawthorne Boulevard, Suite 800, Torrance, CA, USA, 90503
Emmaus Life Sciences Inc is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sales of the Company's product Endari (prescription grade L-glutamine oral powder), to reduce the acute complications of sickle cell disease (SCD) in adult and pediatric patients five years of age and older. Endari is reimbursable by the Centers for Medicare and Medicaid Services, and every state provides coverage for Endari for outpatient prescriptions to all eligible Medicaid enrollees within their state Medicaid programs. Endari is also reimbursable by many commercial payors.